Commercial sales and marketing agreement enhances 3RnD’s mechanistic toxicity screening panel, and expands the reach of ...
The collaboration will leverage Abalone Bio’s Functional Antibody Selection Technology platform for an undisclosed target EMERYVILLE, CA, UNITED STATES, January 6 ...
“Abalone Bio’s FAST platform’s capability to generate functionally active GPCR antibodies, presents an opportunity to push the boundaries of therapeutic antibody discovery,” said Richard Yu, PhD, ...
SCHINDELLEGI, SCHWYZ, SWITZERLAND, March 18, 2026 /EINPresswire.com/ — AsedaSciences ®, a leader in predictive toxicity data integration and chemical safety ...
“Abalone Bio’s FAST platform’s capability to generate functionally active GPCR antibodies, presents an opportunity to push the boundaries of therapeutic antibody discovery,” said Richard Yu, PhD, ...
当前正在显示可能无法访问的结果。
隐藏无法访问的结果